24
Participants
Start Date
February 4, 2025
Primary Completion Date
July 11, 2025
Study Completion Date
July 11, 2025
PF-07248144
Period 1: Participants received Form 1 in a single dose of tablet fasted Period 2: Participants received Form 5 in a single dose of tablet fasted
PF-07248144
Period 1: Participants received Form 5 in a single dose of tablet fasted Period 2: Participants received Form 1 in a single dose of tablet fasted
PF-07248144
Period 1: Fasted participants received a single dose of tablet of Form 1 orally Period 2: Participants received a single dose of tablet orally of Form 5 in a fed state
Pfizer Clinical Research Unit - New Haven, New Haven
Lead Sponsor
Pfizer
INDUSTRY